Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

环孢素软胶囊 - NMPA Drug Approval Details

Approvals/NMPA/Ciclosporin Soft Capsules

Approved

化学药品

Ciclosporin Soft Capsules

Teva Czech Industries s.r.o.🇨🇳 National Medical Products Administration

Approval Date: Jun 28, 2018
Approval ID: 7MaoUm3IkcU
Company: Teva Czech Industries s.r.o.
Type: 化学药品

Approval Details

Approval Id: 7MaoUm3IkcU
Approval Number: H20120153
Generic Name: 环孢素软胶囊
Generic Name En: Ciclosporin Soft Capsules
Drug Type: 化学药品
Dosage Form: 胶囊剂
Strength: 50mg
Reg Date: 2018-06-28
Expired Date: 2023-06-27
Company Name: Teva Czech Industries s.r.o.
Company Address: Ostravská 29, 747 70 Opava 9, Czech Republic
Production Company Name: Teva Czech Industries s.r.o.
Production Company Address: Ostravská 29, 747 70 Opava 9, Czech Republic
Company Detail Path: /organization/teva-czech-industries-s-r-o
Production Company Detail Path: /organization/teva-czech-industries-s-r-o

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Jun 28, 2018

Approval ID

7MaoUm3IkcU

Type

化学药品

Back to NMPA Approvals